IP Library Granted Patent US 11,576,818
Granted Patent B2
US 11,576,818 · App. 16/960,964 · Granted Feb 14, 2023

Negative pressure wound therapy dressings with local oxygen generation for topical wound therapy and related methods

Inventors: Justin Alexander Long (San Antonio, TX); Christopher Brian Locke (Blandford Forum, GB); Timothy Mark Robinson (Blandford Forum, GB); Richard Coulthard (San Antonio, TX)
A61F13/00068A61F13/0216A61M1/73A61M1/743A61M1/90A61M1/915A61M1/94A61M1/962A61M1/964A61M1/966A61F2013/00174A61M1/95A61M2202/0208
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,576,818
App. No.
16/960,964
Granted
Feb 14, 2023
Kind
B2
Abstract

This disclosure includes negative pressure wound therapy dressings with local oxygen generation for topical wound therapy. The dressings ( 18 ) for facilitating delivery of oxygen and application of negative pressure to target tissue include a manifold ( 46 ) that defines a plurality of gas passageways ( 50 ) and is configured to allow communication of oxygen to the target tissue; an oxygen-generating material ( 146 ) that is configured to release oxygen when exposed to water; a gas-occlusive layer ( 74 ) configured to be disposed over the manifold and the oxygen-generating material and coupled to tissue surrounding the target tissue such that an interior volume containing the manifold and the oxygen-generating material is defined between the gas-occlusive layer and the target tissue; and a port ( 94 ) coupled to the gas-occlusive layer and configured to be coupled to a negative pressure source.

Claims (52)

1. A dressing for facilitating delivery of oxygen and application of negative pressure to target tissue, the dressing comprising:

a patient-interface layer configured to be in contact with the target tissue;

a liquid control layer configured to be disposed adjacent to the patient-interface layer and further configured to restrict communication of exudate toward the target tissue;

a manifold that defines a plurality of gas passageways and is configured to allow communication of oxygen to the target tissue;

an oxygen-generating assembly comprising:

a container including a sidewall that defines a chamber, at least a portion of the sidewall being gas-occlusive; and

an oxygen-generating material disposed within the chamber and configured to release oxygen when exposed to water; and

a gas-occlusive layer configured to be disposed over the manifold and the oxygen-generating assembly and coupled to tissue surrounding the target tissue such that: an interior volume containing the manifold and the oxygen-generating assembly is defined between the gas-occlusive layer and the target tissue; and

the gas-occlusive layer limits escape of oxygen from the interior volume between the gas-occlusive layer and the tissue surrounding the target tissue;

wherein the oxygen-generating assembly includes one or more valves configured to permit fluid communication between the chamber and the interior volume.

2. The dressing of claim 1 , wherein the oxygen-generating assembly comprises a water —sorbent material and/or a carbon dioxide-sorbent material disposed within the chamber.

3. The dressing of claim 1 , comprising one or more valves in fluid communication between the chamber and the interior volume, at least one of the one or more valves is movable between:

a first position; and

a second position in which fluid communication between the chamber and the interior volume through the valve is more restricted than when the valve is in the first position.

4. The dressing of claim 3 , wherein at least one of the one or more valves is configured to move toward;

the second position if pressure within the interior volume meets or falls below a threshold pressure; and

the first position if pressure within the chamber meets or rises above the threshold pressure or at least a threshold value above the threshold pressure.

5. The dressing of claim 4 , comprising:

a controller configured to move at least one of the one or more valves between the first and second positions; and

one or more sensors configured to capture data indicative of pressure within the interior volume;

wherein the controller is configured to move at least one of the one or more valves between the first and second positions based, at least in part, on data captured by the one or more sensors.

6. The dressing of claim 5 , comprising a negative pressure source configured to be in fluid communication with the interior volume, wherein the controller is configured to control the negative pressure source based, at least in part, on data captured by the one or more sensors.

7. The dressing of claim 6 , wherein the controller is configured to deactivate the negative pressure source if pressure within the interior volume, as indicated by data captured by at least one of the one or more sensors, meets or falls below the threshold pressure.

8. The dressing of claim 6 , wherein the controller is configured to activate the negative pressure source to reduce pressure within the interior volume if pressure within the interior volume, as indicated by data captured by at least one of the one or more sensors, meets or rises above a threshold pressure.

9. The dressing of claim 5 , wherein the controller is configured to move at least one of the one or more valves toward the second position upon or after activation of the negative pressure source.

10. The dressing claim 5 , wherein the controller is configured to move at least one of the one or more valves toward the first position upon or after deactivation of the negative pressure source.

11. A method for delivering oxygen and applying negative pressure to target tissue, the method comprising:

coupling a dressing to the target tissue, the dressing comprising;

a patient-interface layer configured to be in contact with the target tissue;

a liquid control layer configured to be disposed adjacent to the patient-interface layer and further configured to restrict communication of exudate toward the target tissue;

a manifold that defines a plurality of gas passageways, an oxygen-generating material that is configured to release oxygen when exposed to water, and

a gas-occlusive layer to a patient's tissue such that the gas-occlusive layer is disposed over the manifold and is coupled to tissue surrounding the target tissue such that:

an interior volume is defined between the gas-occlusive layer and the target tissue; and

the gas-occlusive layer limits escape of oxygen from the interior volume between the gas-occlusive layer and the tissue surrounding the target tissue; and

an oxygen-generating assembly configured to be disposed within the interior volume, the oxygen-generating assembly comprising:

a container including a sidewall that defines a chamber, at least a portion of the sidewall being gas-occlusive; and

an oxygen-generating material disposed within the chamber and configured to release oxygen when exposed to water, and

one or more valves in fluid communication between the chamber and the interior volume, at least one of the one or more valves movable between:

a first position; and

a second position in which fluid communication between the chamber and the interior volume through the valve is more restricted than when the valve is in the first position; and

reducing pressure within the interior volume.

12. The method of claim 11 , wherein reducing pressure within the interior volume is performed using a negative pressure source that is in fluid communication with the interior volume.

13. The method of claim 11 , moving the at least one of the one or more valves toward the first position if pressure within the chamber meets or rises above a threshold pressure.

14. The method of claim 11 , moving the at least one of the one or more valves toward the second position if pressure within the interior volume meets or falls below a threshold pressure.

15. The method of claim 11 , wherein the dressing comprises one or more sensors configured to capture data indicative of pressure within the interior volume and movement of the at least one of the one or more valves between the first and second position is based, at least in part, on data captured by the one or more sensors.

16. The method of claim 15 , wherein the dressing comprises a controller configured to move the at least one of the one or more valves between the first and second positions based, at least in part, on data captured by the one or more sensors.

17. The method of claim 15 , wherein:

reducing pressure within the interior volume is performed using a negative pressure source that is in fluid communication with the interior volume; and

controlling the negative pressure source based, at least in part, on data captured by the one or more sensors.

18. The method of claim 17 , actuating the negative pressure source to reduce the negative pressure within the interior volume if pressure within the interior volume, as indicated by data captured by at least one of the one or more sensors, meets or falls below a threshold pressure.

19. The method of claim 17 , actuating the negative pressure source to increase the negative pressure within the interior volume if pressure within the interior volume, as indicated by data captured by at least one of the one or more sensors, meets or rises above a threshold pressure.

20. The dressing of claim 1 , comprising a negative pressure source configured to be in fluid communication with the interior volume.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066444/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0636 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY EXECUTION DATE PREVIOUSLY RECORDED ON REEL 054200 FRAME 0261. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 3, 2020
From: COULTHARD, RICHARD
To: KCI UK HOLDINGS LIMITED
Reel/Frame 054293/0136 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2020
From: KCI UK HOLDINGS LIMITED
To: KCI LICENSING, INC.
Reel/Frame 054209/0226 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2020
From: LONG, JUSTIN ALEXANDER; LOCKE, CHRISTOPHER BRIAN; ROBINSON, TIMOTHY MARK
To: KCI LICENSING, INC.
Reel/Frame 054215/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2020
From: COULTHARD, RICHARD
To: KCI UK HOLDINGS LIMITED
Reel/Frame 054200/0261 →